The company's efforts to transition two key therapeutics targeting Alzheimer's disease and psychiatric disorders towards full commercialization|Stephan Jackman,CEO,Alzamend Neuro Inc 00:10:00
Stephan Jackman joined our company as Chief Executive Officer in November 2018. Mr. Jackman was elected as a director in September 2020.20+ years multi-industry experience, specialized in Biotech and Pharmaceutical.